<SEC-DOCUMENT>0001104659-21-076998-index.html : 20210604
<SEC-HEADER>0001104659-21-076998.hdr.sgml : 20210604
<ACCEPTANCE-DATETIME>20210604160609
ACCESSION NUMBER:		0001104659-21-076998
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210602
FILED AS OF DATE:		20210604
DATE AS OF CHANGE:		20210604

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Kelly Leanne M.
		CENTRAL INDEX KEY:			0001398278

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40034
		FILM NUMBER:		21996488

	MAIL ADDRESS:	
		STREET 1:		5110 CAMPUS DRIVE
		CITY:			PLYMOUTH MEETING
		STATE:			PA
		ZIP:			19462

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vallon Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001824293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				824369909
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		TWO LOGAN SQUARE
		STREET 2:		100 N. 18TH STREET, SUITE 300
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		(267) 207-3606

	MAIL ADDRESS:	
		STREET 1:		TWO LOGAN SQUARE
		STREET 2:		100 N. 18TH STREET, SUITE 300
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm2118823d1_4.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm2118823d1_4.html

Document 1 - RAW XML: tm2118823d1_4.xml

</DOCUMENT>
</SEC-DOCUMENT>